Danish Study Finds Better 10-year Outcomes in Patients Off Antipsychotics
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
“Antipsychotic Medication for Children Could Have Lasting Effects, Research Suggests”
Neuroscientists have just released the results of a study on the long-term use of antipsychotic drugs in children. The growing brain adapts to the...
Despite Claims, EPA Supplement Does Not Improve ADHD Symptoms in Youth
A new study reports that the supplement EPA improved ADHD symptoms but a closer look calls these results into question.
Outcome Reporting Bias in Antipsychotic Medication Trials
A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.
Mental Health Nurses Do Not Routinely Assess for Effects of Antipsychotic Medications
Researchers believe that side-effect monitoring is critical because of the increase in the use of antipsychotics
Study Shows Success With Reduced Antipsychotic Use
People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.
New Data Show Lack of Efficacy for Antidepressants
An article published this month in the journal BMC Psychiatry suggests that there is a lack of efficacy for SSRIs and that they significantly increase the risk of serious side effects.
Researcher Challenges Clinical Effectiveness of Antidepressants
A new article in BMJ Evidence-Based Medicine addresses common misinterpretations of the efficacy research on antidepressants.
Psychiatric Drug Ads Lead to More Prescriptions and Worse Treatment
A new analysis published in the The Journal of Clinical Psychiatry investigates the public health effects of direct-to-consumer advertisements for psychiatric drugs. The researchers...
Is Long-term Use of Benzodiazepines a Risk for Cancer?
A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.
More Psychological Supports Needed to Manage Antidepressant Discontinuation
Study reviews psychological interventions for antidepressant discontinuation.
BPS Releases Review of Alternatives to Antipsychotics
BPS releases report encouraging behavioral interventions for people with dementia, rather than antipsychotics
Researchers Push Back Against Recommendation to Combine Antidepressants for Suicide Prevention
Researchers challenge the recommendation of starting two antidepressants simultaneously to increase preventative effects against suicide.
Researchers Challenge Interpretation of Antidepressant Meta-analysis
Researchers question the overstated results of a large antidepressant meta-analysis and point to cultural pressures to turn to these drugs for a quick fix.
Evidence Strengthening that Common Benzodiazepine Sedatives May Cause Dementia
A meta-analysis of studies found that the risk of dementia increased 22% for every additional twenty daily doses of benzodiazepine medications annually.
Researchers Find Paroxetine Harms Developing Brain
Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.
Researchers Question Link Between Genetics and Depression
A new study, published in the journal Molecular Psychiatry, found no link between genetics and the occurrence of depressive symptoms.
Study Links Antidepressants and Decreased Coping Behaviors Across Generations
Biologists found that exposure to antidepressants suppresses important survival behaviors in zebrafish, an effect that persisted across three generations and was found to be more severe for males.
New York Times Issues Correction on RAISE Study Report
Last Tuesday, The New York Times and several other outlets (including Mad In America) reported on the highly-touted results of a study on psychosocial treatment for patients diagnosed with schizophrenia. Now, claims made about the study, which the ‘Times called “the most rigorous trial to date,” are coming under increased scrutiny.
Study Finds ADHD Drugs Alter Developing Brain
A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...
Reasons Not to Believe in Lithium
‘I Don’t Believe in God, But I Believe in Lithium’ is the title of Jamie Lowe’s moving account of her manic depression in the New York Times. The piece reminds us how devastating and frightening this condition can be, so it is understandable that the author put her faith in the miracle cure psychiatrists have been recommending since the 1950s: lithium. The main problem is that there is no study in which people who have been started on lithium have been compared with people who haven’t.
How Do Antidepressants Really ‘Work’?
A recent review, published in Neuroscience & Biobehavioral Reviews, challenges the dominant assumptions about the neurochemical and therapeutic effects of Selective Serotonin Reuptake Inhibitors...
Certain Antihypertensive Drugs Linked to Mood Disorders
A new study suggests that some antihypertensive drugs are associated with increased risk of bipolar disorder and depression, while other antihypertensive drugs are actually associated with decreased risk.
SSRI Antidepressants Increase Surgery Risks
There is accumulating evidence that taking SSRI antidepressants increases the risk of bleeding and other complications during surgery, according to a review published in the British Journal of Anaesthesia.
“Psychiatric Drug—Not Antibiotic—Messes with Gut Microbes, Spurs Obesity”
In a series of experiments in mice, researchers found that the drug risperidone alters gut microbes, which in turn profoundly influence metabolism, weight, and overall health.
